Skip to main content

Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis

The Original Article was published on 12 June 2020

Correction to: BMC Infect Dis 20, 410 (2020)

https://doi.org/10.1186/s12879-020-05126-z

Following publication of the original article [1], the authors identified an error in Fig. 3. The correct figure is given below.

Fig. 3
figure1

Forest plots of incidence of CM among CrAg + persons receiving azole vs. no intervention or placebo. Abbreviations: M-H, Mantel Haenszel; CI, confidence interval. (“Azole inter” means “Azole drug intervention”, “No inter or plac” mean “No intervention or placebo”

The original article [1] has been corrected.

Reference

  1. 1.

    Li, et al. The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis. BMC Infect Dis. 2020;20:410. https://doi.org/10.1186/s12879-020-05126-z.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Yaokai Chen.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Li, Y., Huang, X., Chen, H. et al. Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis. BMC Infect Dis 21, 604 (2021). https://doi.org/10.1186/s12879-021-06132-5

Download citation